Chloroacetaldehyde	chloroacetaldehyde	S_chemical	O
and	and	O	O
its	its	O	O
contribution	contribution	O	O
to	to	O	O
urotoxicity	urotoxicity	S_chemical	O
during	during	O	O
treatment	treatment	O	O
with	with	O	O
cyclophosphamide	cyclophosphamide	S_chemical	O
or	or	O	O
ifosfamide	ifosfamide	S_chemical	O
.	.	O	O

An	an	O	O
experimental	experimental	O	O
study/short	study/short	O	O
communication	communication	O	O
.	.	O	O

Based	based	O	O
on	on	O	O
clinical	clinical	O	O
data	data	O	O
,	,	O	O
indicating	indicating	O	O
that	that	O	O
chloroacetaldehyde	chloroacetaldehyde	S_chemical	O
(	(	O	O
CAA	caa	O	S_disease
)	)	O	O
is	is	O	O
an	an	O	O
important	important	O	O
metabolite	metabolite	O	O
of	of	O	O
oxazaphosphorine	oxazaphosphorine	O	O
cytostatics	cytostatics	S_chemical	O
,	,	O	O
an	an	O	O
experimental	experimental	O	O
study	study	O	O
was	was	O	O
carried	carried	O	O
out	out	O	O
in	in	O	O
order	order	O	O
to	to	O	O
elucidate	elucidate	O	O
the	the	O	O
role	role	O	O
of	of	O	O
CAA	caa	O	S_disease
in	in	O	O
the	the	O	O
development	development	O	O
of	of	O	O
hemorrhagic	hemorrhagic	O	B_disease
cystitis	cystitis	O	S_disease
.	.	O	O

The	the	O	O
data	data	O	O
demonstrate	demonstrate	O	O
that	that	O	O
CAA	caa	O	S_disease
after	after	O	O
i.v	i.v	O	O
.	.	O	O
administration	administration	O	O
does	does	O	O
not	not	O	O
contribute	contribute	O	O
to	to	O	O
bladder	bladder	O	O
damage	damage	O	O
.	.	O	O

When	when	O	O
instilled	instilled	O	O
directly	directly	O	O
into	into	O	O
the	the	O	O
bladder	bladder	O	O
,	,	O	O
CAA	caa	O	S_disease
exerts	exerts	O	O
urotoxic	urotoxic	O	O
effects	effects	O	O
,	,	O	O
it	it	O	O
is	is	O	O
,	,	O	O
however	however	O	O
,	,	O	O
susceptible	susceptible	O	O
to	to	O	O
detoxification	detoxification	O	O
with	with	O	O
mesna	mesna	S_chemical	O
.	.	O	O

